E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 12/9/2005 in the Prospect News Biotech Daily.

Hi-Tech Pharmacal announces 3-for-2 stock split

By Jennifer Chiou

New York, Dec. 9 - Hi-Tech Pharmacal Co., Inc. said its board declared a 3-for-2 stock split effective Jan. 11.

The stock split applies to shareholders of record on Dec. 30.

Based in Amityville, N.Y., Hi-Tech is a specialty pharmaceutical company that develops and markets products for the diabetes marketplace as well as the general health care industry.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.